Ken Frazier: Diverse Boards Create Impactful Companies

As CEO of one of the world’s biggest pharmaceutical company, Ken Frazier has pushed the firm to invest in treatments for serious diseases, particularly those that affect people in developing countries. During a View From The Top conversation at Stanford Graduate School of Business, Frazier discussed how economic inequality breeds political inequality, his early career pivot from law to business, and why it’s vital to do more than just please shareholders. Listen to Frazier in conversation with Geordie Keelan, MBA '18, on this podcast episode: Stanford GSB’s View From the Top is the Dean’s premier speaker series. It launched in 1978 and is supported in part by the F. Kirk Brennan Speaker Series Fund. During student-led interviews and before a live audience, leaders from around the world share insights on effective leadership, their personal core values, and lessons learned throughout their career. View From The Top is the Dean’s premier speaker series. During student-led interviews, leaders from around the world share insights on effective leadership, their personal core values, and lessons learned throughout their career. I See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.